Dendritic cells in sepsis: Potential immunoregulatory cells with therapeutic potential

• Published in: Molecular immunology 2018-09, Vol.101, p.615-626
• Main Author: Kumar, V.
• Format: Article
• Language: English
• Subjects: Animals; Apoptosis; cDCs; Dendritic cells; Dendritic Cells - immunology; Humans; Immunity; Immunometabolism; Immunosuppression; Models, Biological; pDCs; Sepsis; Sepsis - immunology
• ISSN: 0161-5890; 1872-9142
• DOI: 10.1016/j.molimm.2018.07.007

[Display omitted] •Sepsis is a disease of immune dysregulation.•DCs are regulator of immune homeostasis and inflammatory process.•Sepsis-induces apoptotic death of DCs and tolerogenic DCs.•Sepsis reprograms immunometabolic status of DCs.•Targeting DCs may be a future novel immunomodulatory or immunotherapeutic approach for sepsis. Sepsis is a disease of dysfunctional immune response against the pathogen causing a profound immune-mediated damage to the vital organs and death of the patient in most cases. However, when sepsis is described much attention is given to monocytes/macrophages, complement system, neutrophils, cytokine storm, and T cells. Dendritic cells (DCs) get less attention in this scenario despite comprising the major immune cell population. Therefore the present review is designed to highlight the importance of DCs in the pathogenesis of sepsis, sepsis-associated immunosuppression, and organ damage. The article starts with an introduction of sepsis as a major medical problem needing an urgent therapeutic targeting. Thereafter it provides a brief information regarding classical and plasmacytoid DCs and their role in the maintenance of immune homeostasis. The subsequent sections describe the role of DCs in the immunopathogenesis of sepsis via immunoregulation, impact of sepsis on DCs including their immunometabolic changes, and their therapeutic targeting during sepsis.